Ardent Health Partners LLC (ARDT)

Ardent Health Partners LLC, listed on the NYSE under the ticker ARDT, is a common stock security tied to Ardent Health, Inc. The company operates a U.S. healthcare network centered on hospitals and clinics, with services spanning internal medicine, general surgery, cardiology, oncology, orthopedics, women’s health, neurology, urology, and emergency care. Its platform also includes ambulatory surgery centers, urgent care centers, free-standing emergency departments, diagnostic imaging centers, primary and specialty care clinics, and telehealth services. In addition, Ardent Health operates acute care, rehabilitation, and surgical hospitals. Founded in 2001 and based in Brentwood, Tennessee, the company became Ardent Health, Inc. in June 2025 and is a subsidiary of EGI-AM Investments, L.L.C.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-ARDT
$11
4.9% Upside
Fair
$12.82
22.3% Upside
Undervalued
Great
0.0%
November 11, 2026
18.9x
1.1x
0.2x
1.478 B
3.412 B
54.9%
36.9%
2.4
389.6%
Valuation • Fair Value

Ardent Health Partners LLC (NYSE-ARDT) Fair Value by Valuation Model

Review the available estimates for Ardent Health Partners LLC (NYSE-ARDT), including DCF Fair Value, Ben Graham Formula Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$11

Estimated upside of 4.9% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$10.06

Discounted cash flow valuation reference.

Ben Graham Formula Value

$6.15

Classic Ben Graham valuation formula reference.

Comps Fair Value

$11.94

Comparable-company valuation reference.

Analyst Price Target

$12.82

Analysts imply upside of 22.3%.

How to read these valuation models

Use the 6 available valuation references for Ardent Health Partners LLC (NYSE-ARDT) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Ardent Health Partners LLC (NYSE-ARDT)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

6.406 B

Current operating scale indicator.

Revenue Forecast

6.464 B

Forward revenue estimate.

EBITDA

422.4 M

Current operating profitability reference.

EBITDA Forecast

500.6 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ardent Health Partners LLC (NYSE-ARDT) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ardent Health Partners LLC (NYSE-ARDT)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.97

No elevated caution signal from this screen.

Altman Z-Score

2.4

Intermediate risk zone.

FCF / Net Income

389.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ardent Health Partners LLC (NYSE-ARDT). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ardent Health Partners LLC (NYSE-ARDT)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 11, 2026

Days to Earnings

54

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Ardent Health Partners LLC (NYSE-ARDT), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ardent Health Partners LLC (NYSE-ARDT) Stock Forecast & Technical Outlook

Review Ardent Health Partners LLC (NYSE-ARDT) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Ardent Health Partners LLC (NYSE-ARDT) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Ardent Health Partners LLC (NYSE-ARDT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Ardent Health Partners LLC (NYSE-ARDT) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Ardent Health Partners LLC (NYSE-ARDT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Ardent Health Partners LLC (NYSE-ARDT) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ardent Health Partners LLC (NYSE-ARDT)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Ardent Health Partners LLC (NYSE-ARDT) has a Buy consensus, with 6 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 6
Hold 4
Sell 0
FAQ Fast Investor Answers

Ardent Health Partners LLC (NYSE-ARDT) Stock FAQ

Data-supported answers about Ardent Health Partners LLC (NYSE-ARDT), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$11
Estimated upside 4.9%
Valuation Rating
Undervalued
Estimated upside of 4.9%
Analyst Target
$12.82
Implied upside 22.3%
Financial Health
Great
Current financial-health read

The current fair value estimate for Ardent Health Partners LLC (NYSE-ARDT) is $11. This implies an estimated upside of 4.9% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 4.9% versus the current market price.

The available analyst price target for Ardent Health Partners LLC (NYSE-ARDT) is $12.82. The analyst target implies estimated upside of 22.3%.

The current financial health read for Ardent Health Partners LLC (NYSE-ARDT) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ardent Health Partners LLC (NYSE-ARDT) is November 11, 2026.

The latest available data indicates no current dividend yield for Ardent Health Partners LLC (NYSE-ARDT).

The current P/E ratio listed for Ardent Health Partners LLC (NYSE-ARDT) is 18.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ardent Health Partners LLC is 1.478 B.

The current enterprise value listed for Ardent Health Partners LLC is 3.412 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ardent Health Partners LLC is NYSE-ARDT, and the stock is listed on NYSE.

Ardent Health Partners LLC (NYSE-ARDT) is listed on NYSE.

The current debt-to-total-capital ratio listed for Ardent Health Partners LLC is 54.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ardent Health Partners LLC is 36.9%. Free float helps investors understand how much of the share base is available for public trading.